国家药监局召开化妆品监管工作座谈会

Core Viewpoint - The National Medical Products Administration (NMPA) held a meeting on December 29 to summarize the regulatory achievements of 2025 and outline key work strategies for 2026, emphasizing the importance of comprehensive regulatory reforms and high-quality development in the cosmetics industry [1] Group 1 - The year 2026 marks the beginning of the "14th Five-Year Plan," highlighting the need for deep implementation of the spirit from the 20th National Congress of the Communist Party and subsequent plenary sessions [1] - The meeting focused on continuous deepening of the entire process regulatory reform and strengthening safety measures across the cosmetics industry [1] - The NMPA aims to promote high-quality development throughout the entire supply chain of the cosmetics industry [1]